Phillip H Lam
Overview
Explore the profile of Phillip H Lam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel S, Raman V, Faselis C, Fonarow G, Lam P, Ahmed A, et al.
JACC Heart Fail
. 2025 Feb;
13(3):467-479.
PMID: 39918536
Background: Chronic kidney disease (CKD) is defined by the KDIGO (Kidney Disease: Improving Global Outcomes) guideline as abnormal kidney structure or function, present for >3 months, with implications for health....
2.
Fraser E, Culver A, Lam P, Hofmeyer M, Sheikh F, Gupta R
JACC Case Rep
. 2024 Dec;
29(22):102738.
PMID: 39691891
Giant cell myocarditis (GCM) and cardiac sarcoidosis share clinical and histologic features, but whether they represent separate processes or lie on an inflammatory cardiomyopathy spectrum is unclear. We present a...
3.
Sin M, Allman R, Faselis C, Aronow W, Brown C, Lam P, et al.
Am J Med
. 2024 Nov;
PMID: 39551174
Background: Renin-angiotensin system (RAS) inhibitors at higher target doses reduce the risk of death in patients with heart failure with reduced ejection fraction (HFrEF). Less is known about their effectiveness...
4.
Lam P, Liu K, Ahmed A, Butler J, Heidenreich P, Anker M, et al.
Am J Med
. 2024 Oct;
138(3):495-503.e1.
PMID: 39424217
Background: National heart failure guidelines recommend quadruple therapy with renin-angiotensin system inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter 2 inhibitors for patients with heart failure with reduced ejection fraction...
5.
Hussien M, Lorente-Ros M, Lam P, Frishman W, Aronow W, Gupta R
Cardiol Rev
. 2024 Jul;
PMID: 39078143
Heart transplant (HT) recipients are more frequently reaching childbearing age given improvement in median survival and outcomes after HT. Although most pregnancies in HT recipients have favorable outcomes, poor fetal...
6.
Oates C, Lawrence L, Bigham G, Meda N, Basyal B, Rao S, et al.
ASAIO J
. 2024 Jul;
71(2):157-163.
PMID: 39074441
The impact of cardiac resynchronization therapy (CRT) in patients receiving durable left ventricular assist device (LVAD) implantation remains unclear and there is no consensus regarding postoperative management. We sought to...
7.
Shao Y, Zhang S, Raman V, Patel S, Cheng Y, Parulkar A, et al.
ESC Heart Fail
. 2024 Jun;
11(5):3155-3166.
PMID: 38873749
Aims: Heart failure (HF) is a clinical syndrome with no definitive diagnostic tests. HF registries are often based on manual reviews of medical records of hospitalized HF patients identified using...
8.
Patel S, Raman V, Zhang S, Deedwania P, Zeng-Treitler Q, Wu W, et al.
Eur J Heart Fail
. 2024 May;
26(5):1251-1260.
PMID: 38700246
Aims: According to the Kidney Disease: Improving Global Outcomes (KDIGO) guideline, the definition of chronic kidney disease (CKD) requires the presence of abnormal kidney structure or function for >3 months...
9.
Gupta R, Bermudez F, Vora T, Homayouni N, Weissman G, Kadakkal A, et al.
Am J Cardiol
. 2024 Apr;
222:35-38.
PMID: 38663574
No abstract available.
10.
Alagiakrishnan K, Mah D, Aronow W, Lam P, Frishman W, Ahmed A, et al.
Cardiol Rev
. 2024 Feb;
PMID: 38421170
Understanding noncardiovascular comorbidities and geriatric syndromes in elderly patients with heart failure (HF) is important as the average age of the population increases. Healthcare professionals need to consider these complex...